3-45524062-A-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_015340.4(LARS2):​c.2358A>G​(p.Val786Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.976 in 1,613,866 control chromosomes in the GnomAD database, including 773,893 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.88 ( 61659 hom., cov: 30)
Exomes 𝑓: 0.99 ( 712234 hom. )

Consequence

LARS2
NM_015340.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.552

Publications

19 publications found
Variant links:
Genes affected
LARS2 (HGNC:17095): (leucyl-tRNA synthetase 2, mitochondrial) This gene encodes a class 1 aminoacyl-tRNA synthetase, mitochondrial leucyl-tRNA synthetase. Each of the twenty aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. [provided by RefSeq, Jul 2008]
LARS2 Gene-Disease associations (from GenCC):
  • hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Perrault syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Perrault syndrome 4
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 3-45524062-A-G is Benign according to our data. Variant chr3-45524062-A-G is described in ClinVar as Benign. ClinVar VariationId is 226704.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.552 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.991 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LARS2NM_015340.4 linkc.2358A>G p.Val786Val synonymous_variant Exon 20 of 22 ENST00000645846.2 NP_056155.1 Q15031

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LARS2ENST00000645846.2 linkc.2358A>G p.Val786Val synonymous_variant Exon 20 of 22 NM_015340.4 ENSP00000495093.1 Q15031

Frequencies

GnomAD3 genomes
AF:
0.883
AC:
134263
AN:
152002
Hom.:
61622
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.602
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.952
Gnomad ASJ
AF:
0.997
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.958
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.968
Gnomad NFE
AF:
0.998
Gnomad OTH
AF:
0.909
GnomAD2 exomes
AF:
0.965
AC:
242562
AN:
251454
AF XY:
0.972
show subpopulations
Gnomad AFR exome
AF:
0.592
Gnomad AMR exome
AF:
0.977
Gnomad ASJ exome
AF:
0.996
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.998
Gnomad OTH exome
AF:
0.977
GnomAD4 exome
AF:
0.985
AC:
1440007
AN:
1461746
Hom.:
712234
Cov.:
42
AF XY:
0.986
AC XY:
716874
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.589
AC:
19696
AN:
33454
American (AMR)
AF:
0.973
AC:
43519
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.995
AC:
26013
AN:
26134
East Asian (EAS)
AF:
1.00
AC:
39690
AN:
39698
South Asian (SAS)
AF:
0.965
AC:
83264
AN:
86256
European-Finnish (FIN)
AF:
1.00
AC:
53418
AN:
53420
Middle Eastern (MID)
AF:
0.972
AC:
5605
AN:
5768
European-Non Finnish (NFE)
AF:
0.999
AC:
1110277
AN:
1111910
Other (OTH)
AF:
0.969
AC:
58525
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
777
1554
2332
3109
3886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21620
43240
64860
86480
108100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.883
AC:
134359
AN:
152120
Hom.:
61659
Cov.:
30
AF XY:
0.887
AC XY:
65972
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.603
AC:
24948
AN:
41398
American (AMR)
AF:
0.952
AC:
14547
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.997
AC:
3461
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5166
AN:
5166
South Asian (SAS)
AF:
0.958
AC:
4625
AN:
4828
European-Finnish (FIN)
AF:
1.00
AC:
10616
AN:
10616
Middle Eastern (MID)
AF:
0.969
AC:
285
AN:
294
European-Non Finnish (NFE)
AF:
0.998
AC:
67880
AN:
68042
Other (OTH)
AF:
0.910
AC:
1919
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
562
1123
1685
2246
2808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.944
Hom.:
38818
Bravo
AF:
0.865
Asia WGS
AF:
0.958
AC:
3332
AN:
3478
EpiCase
AF:
0.997
EpiControl
AF:
0.997

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val786Val in exon 20 of LARS2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 38.2% (1681/4406) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs267220). -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 16, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Perrault syndrome 4 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
5.6
DANN
Benign
0.78
PhyloP100
0.55
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267220; hg19: chr3-45565554; COSMIC: COSV108100757; API